Arena BioWorks

Last updated

Arena BioWorks is a recently-announced biomedical institute that will be located in Kendall Square in Cambridge, Massachusetts. Having attracted notable scientists, the institute is led by Stuart Schreiber. [1]

The institute has $500 million in initial private funding backed by individuals including Steve Pagliuca, Michael Dell, Michael Chambers, Jim Breyer, and Elisabeth DeLuca. [2] [3]

Related Research Articles

<span class="mw-page-title-main">David Baltimore</span> American biologist (born 1938)

David Baltimore is an American biologist, university administrator, and 1975 Nobel laureate in Physiology or Medicine. He is a professor of biology at the California Institute of Technology (Caltech), where he served as president from 1997 to 2006. He founded the Whitehead Institute and directed it from 1982 to 1990. In 2008, he served as president of the American Association for the Advancement of Science in 2008.

The University of Texas Southwestern Medical Center is a public academic health science center in Dallas, Texas. With approximately 23,000 employees, more than 3,000 full-time faculty, and nearly 4 million outpatient visits per year, UT Southwestern is the largest medical school in the University of Texas System and the State of Texas.

UMass Chan Medical School is a public medical school in Worcester, Massachusetts. It is part of the University of Massachusetts system. It is home to three schools: the T.H. Chan School of Medicine, the Morningside Graduate School of Biomedical Sciences, and the Tan Chingfen Graduate School of Nursing, as well as a biomedical research enterprise and a range of public-service initiatives throughout the state.

<span class="mw-page-title-main">Vertex Pharmaceuticals</span> American pharmaceutical company

Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry. It maintains headquarters in South Boston, Massachusetts, and three research facilities, in San Diego, California, and Milton Park, Oxfordshire, England.

A neurochip is an integrated circuit chip that is designed for interaction with neuronal cells.

<span class="mw-page-title-main">Robert S. Langer</span> American scientist

Robert Samuel Langer Jr. FREng is an American biotechnologist, businessman, chemical engineer, chemist, and inventor. He is one of the eight Institute Professors at the Massachusetts Institute of Technology.

<span class="mw-page-title-main">Medical research</span> Wide array of research

Medical research, also known as experimental medicine, encompasses a wide array of research, extending from "basic research", – involving fundamental scientific principles that may apply to a preclinical understanding – to clinical research, which involves studies of people who may be subjects in clinical trials. Within this spectrum is applied research, or translational research, conducted to expand knowledge in the field of medicine.

<span class="mw-page-title-main">Jason Pontin</span> British-born venture capitalist and journalist

Jason Matthew Daniel Pontin is a British-born venture capitalist and journalist. He is a General Partner at the venture capital firm of DCVC in Palo Alto, and is a board member and seed investor in a number of life sciences companies. He is the former editor in chief and publisher of MIT Technology Review.

<span class="mw-page-title-main">Necco</span> Candy manufacturer

Necco was an American manufacturer of candy created in 1901 as the New England Confectionery Company through the merger of several small confectionery companies located in the Greater Boston area, with ancestral companies dating back to the 1840s.

<span class="mw-page-title-main">The Forsyth Institute</span> Craniofacial research institute

The Forsyth Institute, located in Cambridge, Massachusetts, is one of the leading centers for dental and craniofacial research in the world. It was envisioned in 1908 by James Forsyth, who left $500,000 in his will for the establishment of a dental infirmary for poor children in Boston. Forsyth would pass away before establishing the institute leaving his two brothers, Dr. Thomas Alexander Forsyth And John Forsyth, the task of establishing the dental infirmary.

James Sherley is a biological engineer and the founder of Asymmetrex, an adult stem cell research center. He has also conducted research at the Boston Biomedical Research Institute and Massachusetts Institute of Technology (MIT). Sherley filed a suit against the government in Sherley v. Sebelius, resulting in a protracted legal battle attempting to ban the government from funding any research relating to embryonic stem cells.

<span class="mw-page-title-main">David Edwards (engineer)</span> American biomedical engineer

David A. Edwards is an American biomedical engineer, and the founder of Sensory Cloud. He was the Gordon McKay Professor of the Practice of Biomedical Engineering at Harvard University.

<span class="mw-page-title-main">Stephen Pagliuca</span> American businessman (born 1955)

Stephen Gerard Pagliuca is an American private equity investor, co-chairman of Bain Capital, and co-owner of the Boston Celtics of the National Basketball Association (NBA) and Atalanta of Italian Serie A association football league.

Laurie Hollis Glimcher is an American physician-scientist who was appointed president and CEO of Dana–Farber Cancer Institute in October 2016. She was elected a Member of the American Philosophical Society in 2019.

Lab Central, Inc., also known as LabCentral, is a non-profit organization started in November 2013. Operating over 225,000 sq. feet in Cambridge and on the Harvard University campus, LabCentral offers a network of fully permitted laboratory and office spaces for as many as 125 biotech start-ups comprising approximately 1000 scientists and entrepreneurs in the heart of Kendall Square. Additionally, LabCentral is committed to creating a more sustainable and inclusive biotech system supporting developments in STEM, workforce training, and next generation entrepreneurship through its LabCentral Ignite initiative. LabCentral is also home to Gallery 1832 which engages the local community to celebrate artistic innovation.

<span class="mw-page-title-main">Foundation for the National Institutes of Health</span>

The Foundation for the National Institutes of Health (FNIH) is a not-for-profit, 501(c)(3) charitable organization established by the US Congress in 1990. Located in North Bethesda, MD, the FNIH raises private-sector funds, and creates and manages alliances with public and private institutions in support of the mission of the National Institutes of Health (NIH).

<span class="mw-page-title-main">Boston bid for the 2024 Summer Olympics</span> Bid to bring the Olympics to Boston

The Boston 2024 Partnership was a short-lived, privately funded bid to bring the 2024 Summer Olympics to the city of Boston, Massachusetts. The official proposal was submitted on September 12, 2014. On January 8, 2015, the United States Olympic Committee (USOC) chose Boston to compete with candidates around the world, and the International Olympic Committee (IOC) would select the host city in 2017.

Molly S. Shoichet, is a Canadian science professor, specializing in chemistry, biomaterials and biomedical engineering. She was Ontario's first Chief Scientist. Shoichet is a biomedical engineer known for her work in tissue engineering, and is the only person to be a fellow of the three National Academies in Canada.

Ocean Biomedical is a new-generation American biopharmaceutical company based in Providence, Rhode Island. The company has product candidates addressing malaria, pulmonary fibrosis, and lung cancer. Ocean Biomedical was founded by Indian-American physician Chirinjeev Kathuria with Scientific Co-founders Jack Elias and Dr. Jonathan Kurtis, both from Brown University’s Medical School faculty. They aim to build a pipeline of preclinical, clinical, and commercial drug development by bringing together interdisciplinary expertise and resources.

The Wyss Institute for Biologically Inspired Engineering is a cross-disciplinary research institute at Harvard University focused on bridging the gap between academia and industry by drawing inspiration from nature's design principles to solve challenges in health care and the environment. It is focused on the field of biologically inspired engineering to be distinct from bioengineering and biomedical engineering. The institute also has a focus on applications, intellectual property generation, and commercialization.

References

  1. "For-profit biomedical institute, backed by billionaires, launches in Cambridge to speed drug discovery - The Boston Globe". BostonGlobe.com.
  2. Copeland, Rob (January 12, 2024). "The Billionaires Spending a Fortune to Lure Scientists Away From Universities". The New York Times via NYTimes.com.
  3. Hannah Green (January 12, 2024). "Steve Pagliuca, others want to 'turbocharge' drug discovery with new Cambridge institute Email Share Share Tweet". Boston Business Journal. Retrieved January 16, 2024 via bizjournals.com.